Table 1.
Total | Cases |
Controls |
P‡ | ||
---|---|---|---|---|---|
183 (N) | 100 (%)∗ | 182† (N) | 100 (%)∗ | ||
Age at breast cancer diagnosis§ | |||||
Median age (IQR) in years | 50.2 | 45.8-54.7 | 50.2 | 45.5-54.6 | |
<40 (22-39) y | 9 | 4.9 | 10 | 5.5 | |
40-49 y | 78 | 42.6 | 78 | 42.9 | |
50-59 y | 77 | 42.1 | 75 | 41.2 | |
≥60 (60-70) y | 19 | 10.4 | 19 | 10.4 | |
Year of breast cancer diagnosis§ | |||||
1970-1979 | 41 | 22.4 | 41 | 22.5 | |
1980-1989 | 95 | 51.9 | 92 | 55.6 | |
1990-1999 | 29 | 15.9 | 34 | 18.7 | |
2000-2009 | 18 | 9.8 | 15 | 8.2 | |
Time to MI/cutoff date§,¶ | |||||
Median time (IQR) in years | 13.6 | 10.3-18.2 | 13.7 | 10.3-18.2 | |
<5 (1-4) y | 13 | 7.1 | 13 | 7.1 | |
5-9 y | 31 | 16.9 | 31 | 17.0 | |
10-14 y | 60 | 32.8 | 59 | 32.4 | |
15-19 y | 48 | 26.2 | 48 | 26.4 | |
≥20 (20-29) y | 31 | 16.9 | 31 | 17.0 | |
Age at MI diagnosis/cutoff date¶ | |||||
Median age (IQR) in years | 64.2 | 58.5-70.2 | 63.9 | 58.5-70.2 | |
<50 (40-49) y | 7 | 3.8 | 8 | 4.4 | |
50-59 y | 51 | 27.9 | 50 | 27.5 | |
60-69 y | 74 | 40.4 | 74 | 40.7 | |
70-79 y | 45 | 24.6 | 44 | 24.2 | |
≥80 (83-89) y | 6 | 3.3 | 6 | 3.3 | |
Laterality of breast cancer | |||||
Right | 85 | 46.4 | 81 | 44.5 | |
Left | 98 | 53.6 | 101 | 55.5 | .72 |
Nodal status | |||||
Negative | 106 | 57.9 | 107 | 58.8 | |
Positive | 75 | 41.0 | 74 | 40.7 | |
Unknown | 2 | 1.1 | 1 | 0.5 | .91 |
Tumor size∗ | |||||
<2 cm | 58 | 31.7 | 76 | 41.8 | |
2-5 cm | 88 | 48.1 | 72 | 39.6 | |
≥5 cm | 6 | 3.3 | 10 | 5.5 | |
Unknown | 31 | 16.9 | 24 | 13.2 | .09 |
Abbreviations: BC = breast cancer; IQR = interquartile range; MI = myocardial infarction.
Percentages may not total 100 because of rounding.
Cases and controls were selected with replacement. When an individual appeared as a control twice within the same stratum, it was included only once in the analysis (n = 1).
P value for difference between tumor characteristics of cases and controls, calculated within strata (defined by matching variables) and excluding the unknown category.
Matching variables.
Derived from matching factors. Cutoff date for controls was defined as the date of BC diagnosis plus a time interval equal to the time between BC diagnosis and MI diagnosis for the paired case.